HIV Infections
📧 Sign up to get email alerts when something new happens for HIV Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-03-20Clinical Trial Update: Provision of HIV Self-Test Kit to Emergency Department Patients [NA]
Completed clinical trial evaluating provision of HIV self-test kits to emergency department patients; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-19Clinical Trial Update: Study to Evaluate the Pharmacokinetic (PK) Interactions Between GSK3640254 and Dolutegravir (DTG) [Phase 1]
Phase 1 study evaluating pharmacokinetic interactions between GSK3640254 and dolutegravir (DTG) in HIV infections; results posted after comp…
-
CLINICAL_TRIALS trial_result · 2020-02-21Clinical Trial Update: Safety and Efficacy of Reduced Versus Standard Dose Efavirenz (EFV) Plus Two Nucleotides in Antiretroviral-naïve Adults. [Phase 3]
Phase 3 trial comparing reduced-dose versus standard-dose efavirenz with two NRTIs in antiretroviral-naïve adults; completed with posted res…
-
CLINICAL_TRIALS trial_result · 2020-02-07Clinical Trial Update: Therapeutic Drug Monitoring Study of Reduced-Dose Efavirenz (400 mg) in Combo Tablet for Patients Receiving Atripla With Viral Suppression in Taiwan [Phase 3]
Phase 3 trial assessing reduced-dose efavirenz (400 mg) in a fixed-dose combination for virologic suppression in HIV patients.
-
CLINICAL_TRIALS trial_result · 2020-01-31Clinical Trial Update: Efficacy And Security Of Annual And Biennial Zoledronic Acid For Osteoporosis Treatment In An HIV-Infected Patients' Cohort [Phase 4]
Phase 4 trial update evaluating efficacy and safety of annual and biennial zoledronic acid for osteoporosis in HIV-infected patients.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-01-03Clinical Trial Update: Pharmacodynamics, Safety and Pharmacokinetics of BMS-663068, an HIV Attachment Inhibitor, in HIV-1 [Phase 2]
Phase 2 trial update on pharmacodynamics, safety, and pharmacokinetics of BMS-663068 (HIV attachment inhibitor) in HIV-1.
-
CLINICAL_TRIALS trial_result · 2019-12-23Clinical Trial Update: Isoprinosine in HIV Patients With Viral Load > 50 y < 200 Copies/mL [Phase 4]
Phase 4 clinical trial update for Isoprinosine in HIV-infected patients with viral load between 50 and 200 copies/mL; status not clearly spe…
-
CLINICAL_TRIALS trial_result · 2019-12-09Clinical Trial Update: To Assess the Relative Bioavailability (BA) of TRIUMEQ® and Dolutegravir and Lamivudine (DTG/3TC) Pediatric Dispersible Tablet Formulations in Healthy Volunteers [Phase 1]
A Phase 1 study assessing the relative bioavailability of DTG/3TC pediatric dispersible tablet formulations in healthy volunteers.
-
CLINICAL_TRIALS trial_result · 2019-12-09Clinical Trial Update: iHIVARNA Clinical Trial in HIV Infected Individuals [Phase 2]
Phase 2 clinical trial update for iHIVARNA in HIV infection has terminated; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-12-05Clinical Trial Update: Peginterferon Alfa-2a, Ribavirin and Epoetin β in Coinfected Patients HCV/HIV Not Responding to Previous Treatment Regimens [Phase 4]
Phase 4 trial update of Peginterferon alfa-2a, ribavirin, and epoetin beta in coinfected HCV/HIV patients not responding to prior regimens.
-
CLINICAL_TRIALS trial_result · 2019-12-05Clinical Trial Update: Evaluate the Efficacy and Security of Darunavir/Ritonavir 900/100 mg Once a Day as an Antiretroviral Treatment Simplification Strategy [Phase 4]
Phase 4 trial evaluating once-daily darunavir/ritonavir as a simplification strategy for antiretroviral therapy in HIV infection.
-
CLINICAL_TRIALS trial_result · 2019-12-05Clinical Trial Update: Clinical Trial Assessing Once Daily Raltegravir Administration (800 mg QD) in HIV-1-Infected Patients Receiving Unboosted Atazanavir (400 mg QD)- Based Antiretroviral Therapy [Phase 4]
Phase 4 clinical trial evaluating once-daily raltegravir (800 mg) with unboosted atazanavir (400 mg) in HIV-1 infected patients; completed s…
-
CLINICAL_TRIALS trial_result · 2019-12-05Clinical Trial Update: Clinical Trial to Assess the Security of the Dose Reduction of Ritonavir in HIV-Infected Patients in Treatment With Tipranavir/Ritonavir 500/200 mg Every 12 Hours [Phase 4]
A Phase 4 clinical trial evaluated the security of reducing ritonavir dose in HIV-infected patients treated with tipranavir/ritonavir 500/20…
-
CLINICAL_TRIALS trial_result · 2019-12-05Clinical Trial Update: Pilot Study to Compare the Pharmacokinetics Parameters in Plasma and Intracellular of Raltegravir Administered Once a Day in Adult Patients Infected With HIV [Phase 4]
Phase 4 trial update studying pharmacokinetics of raltegravir given once daily in adults with HIV, completed.
-
CLINICAL_TRIALS trial_result · 2019-12-04Clinical Trial Update: HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy in Spain [Phase 4]
Phase 4 trial update assessing HIV-1 viral dynamics in subjects initiating raltegravir therapy in Spain.
-
CLINICAL_TRIALS trial_result · 2019-12-04Clinical Trial Update: Saquinavir/Ritonavir in Single Therapy as Maintenance Treatment [Phase 4]
Phase 4 trial updating saquinavir/ritonavir as maintenance therapy in HIV infections.
-
CLINICAL_TRIALS trial_result · 2019-12-04Clinical Trial Update: Study to Evaluate the Influence of Nevirapine to Atazanavir in Steady State Equilibrium in HIV Patients [Phase 4]
Phase 4 clinical trial evaluating the influence of nevirapine on atazanavir in HIV patients has completed.
-
CLINICAL_TRIALS trial_result · 2019-12-04Clinical Trial Update: Viral Kinetics of Treatment With Peginterferon Alpha-2a, Ribavirin and Epoetin β in Patients Coinfected HCV/HIV [Phase 4]
Phase 4 clinical trial analyzing viral kinetics of peginterferon alfa-2a, ribavirin, and epoetin beta in patients coinfected with HCV/HIV; c…
-
CLINICAL_TRIALS trial_result · 2019-11-18Clinical Trial Update: Long-term Immunogenicity of the HIV gp120-NefTat/AS01B Vaccine (GSK SB732461) [Phase 1]
Phase 1 trial update on long-term immunogenicity of the HIV gp120-NefTat/AS01B vaccine (GSK SB732461) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-11-15Clinical Trial Update: The Effectiveness of SMS in Improving Antiretroviral Medication Adherence Among Adolescents Living With HIV in Nigeria [NA]
Clinical trial evaluating SMS messaging to improve antiretroviral adherence in adolescents with HIV in Nigeria; study completed with results…
-
CLINICAL_TRIALS trial_result · 2019-11-14Clinical Trial Update: Pilot Study of Pyridostigmine Upon Immune Activation in HIV-1 Patients Who Have an Inadequate Immune Response [Phase 2]
Phase 2 pilot study evaluating pyridostigmine to enhance immune activation in HIV patients with inadequate immune response; trial completed …
-
CLINICAL_TRIALS trial_result · 2019-11-07Clinical Trial Update: The Safety and Immunogenicity of a Potential HIV Vaccine [Phase 1]
Phase 1 trial assessing safety and immunogenicity of a potential HIV vaccine; results completed and posted.
-
CLINICAL_TRIALS trial_result · 2019-11-07Clinical Trial Update: Safety and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults [Phase 1]
A Phase 1 safety and pharmacokinetic study evaluated rectal administration of dapivirine gel (0.05%) in HIV-1 seronegative adults; results p…
-
CLINICAL_TRIALS trial_result · 2019-11-04Clinical Trial Update: The Maraviroc Central Nervous System (CNS) Study [Phase 1]
Phase 1 clinical trial update for maraviroc CNS study in HIV infections; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-24Clinical Trial Update: Smart Linkage-to-HIV Care Via a Smartphone App [NA]
Clinical trial update on a smartphone app designed to link HIV patients to care; study completed with results posted in 2019.